Moleculin Biotech ( (MBRX) ) just unveiled an update.
On March 24, 2025, Moleculin Biotech, Inc. utilized a corporate presentation for its website, which was detailed in a Current Report on Form 8-K. The presentation, noted as Exhibit 99.1, was shared for informational purposes and not intended for filing under the Securities Exchange Act of 1934 or the Securities Act of 1933.
More about Moleculin Biotech
YTD Price Performance: -38.42%
Average Trading Volume: 5,907,888
Technical Sentiment Signal: Buy
Current Market Cap: $14.5M
For a thorough assessment of MBRX stock, go to TipRanks’ Stock Analysis page.